Skip to main content
Top
Published in: Tumor Biology 9/2015

01-09-2015 | Research Article

RETRACTED ARTICLE: Risperidone promotes differentiation of glioma stem-like cells through the Wnt signaling pathway

Authors: Hao Peng, Bing Jiang, Jiannong Zhao, Bing Chen, Pengcheng Wang

Published in: Tumor Biology | Issue 9/2015

Login to get access

Excerpt

This article has been retracted due to the agreement between the authors and the journal Editor-in-Chief, Torgny Stigbrand. The retraction has been agreed due to the fact that the authors found that the primers that were used for STIM1 were wrong. They actually amplified several other genes as well. When the authors used a new STIM1-specific primer pairs that passed blast control, they could not reproduce the published data. As result, the data does not support the essential conclusion of the authors that risperidone may promote differentiation of glioma stem-like cells through the Wnt signaling pathway. The authors accept full responsibility of this mistake and deeply apologize to the scientific community for the inconvenience. …
Metadata
Title
RETRACTED ARTICLE: Risperidone promotes differentiation of glioma stem-like cells through the Wnt signaling pathway
Authors
Hao Peng
Bing Jiang
Jiannong Zhao
Bing Chen
Pengcheng Wang
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3087-x

Other articles of this Issue 9/2015

Tumor Biology 9/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine